J9353 Injection. margetuximab-cmkb, 5 milligrams
J-Codes
Also known as: margetuximab, Margenza
Injection of margetuximab-cmkb, 5 milligram. An engineered human epidermal growth factor receptor 2 monoclonal antibody.
Clinical Context
Used for HER2-positive metastatic breast cancer with other chemotherapy. Enhanced Fc region for improved antibody-dependent cellular cytotoxicity.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.